INTRODUCTION
There are several data clinical and epidemiological which indicate that myocardial infarction is a main cause of death worldwide 1, 2 . Myocardial infarction can be induced by prolonged ischemia which consequently brings in cell viability, and ultimately cardiac function. In addition, acute myocardial infarction can produce alterations in the topography of both the infarcted and non-infarcted regions of the ventricle 3 . Some reports which indicate the most effective method of limiting necrosis is restoration of blood flow; however, the effects of reperfusion itself may also be associated with tissue injury 4 . In the search of therapeutic alternatives to reduce the ischemia-reperfusion injury, some drugs have been evaluated; for example, there are data which indicate that glibenclamide reduces myocardial damage caused by ischemia/reperfusion in Guinea pig heart via activation of ATP-regulated K + channels 5 . Other study indicates that Cyclosporin A can reduce the ischemia/reperfusion-injury in isolated rat hearts through changes in c AMP levels 6 . In addition, some naphthalene derivatives have been developed to evaluate their biological activity in several animal models; for example, a study showed that the naphthalene derivative ((±)-(R,S)-5, 6-dihydroxy-2-methylamino-1, 2,3,4-tetrahydro-naphthalene hydrochloride) induces protective effects on ischemiareperfusion injury in isolated heart rat via decrease of norepinephrine 7 . Other report, showed that the naphthalene derivative (N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide), exerts cardioprotective effects on the isolated rat hear t exposed to hypothermic and ischemic conditions by blocking the activity of calmodulin 8 . Other data indicates that compound 1,5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalene sulfonamide, significantly improved the recovery of cardiac function during reperfusion-ischemia injury through of reduced of creatine kinase 9 . All these data indicates that differences in the chemical structure of naphthalene derivatives may be in part responsible of activity of these compounds on reperfusion-ischemia injury. To test this information, the present study was designed to investigate the effects induced by a naphthalene derivative in a myocardial infarction/reperfusion model. In addition, to evaluate the molecular mechanism involved in the activity of the naphthalene derivative on left ventricular pressure which were used as pharmacological tools for blocking various biological systems;
propanolol (non-selective ²-receptorblocker) 10 , prazosin (± 1 adrenoreceptor antagonist) 11 , metoprolol (selective ² 1 receptor blocker) 12 , indomethacin (prostaglandin synthesis inhibitor) 13 and nifedipine (antagonist calcium channel type L) 14 .
MATERIAL AND METHODS

Chemical synthesis
The compounds evaluated in this study were purchased from Sigma-Aldrich Co., Ltd. The melting point for the danazol derivative was determined on an Electrothermal (900 model). Infrared spectra (IR) were recorded using KBr pellets on a Perkin Elmer Lambda 40 spectrometer. 1 H and 13 C NMR (nuclear magnetic resonance) spectra were recorded on a Varian VXR-300/5 FT NMR spectrometer at 300 and 75.4 MHz (megahertz) in CDCl 3 (deuterated chloform) using TMS (tetramethylsilane) as internal standard. EIMS (electron impact mass spectroscopy) spectra were obtained with a Finnigan Trace Gas Chromatography Polaris Q Spectrometer. Elementary analysis data were acquired from a Perkin Elmer Ser. II CHNS/0 2400 elemental analyzer.
Synthesis of 2-hydroxy-N-(4-nitrobenzoyl) naphthalene-1-carboximidic acid
A solution of 4-nitrobenzoyl azide (100 mg, 0.52 mmol), 2-hydroxy-1-naphthaldehyde (90 mg, 0.52mmol) and acetic acid (3 mL) in 10 mL of dimethylsulfoxide/methanol (3:1) was stirred for 24 h at room temperature. The reaction mixture was evaporated to dryness under reduced pressure, the residue washed 3 times with water. Then the precipitate was separated and dried at room temperature.
Biological method
All experimental procedures and protocols used in this investigation were reviewed and approved by the Animal care and use Committee of University Autonomous of Campeche (No. PI-420/12) and were in accordance with the guide for the care and use of laboratory animals 15 . Male Wistar rats; weighing 200-250 g were obtained from University Autonomous of Campeche.
Reagents
All drugs were dissolved in methanol and different dilutions were obtained using Krebs-Henseleit solution (d" 0.01%, v/v).
Experimental design
Briefly, the male rat (200 -250 g) was anesthetized by injecting them with pentobarbital at a dose rate of 50 mg/Kg body weight. Then the chest was opened, and a loose ligature passed through the ascending aorta. The heart was then rapidly removed and immersed in ice cold physiologic saline solution. The heart was trimmed of non-cardiac tissue and retrograde perfused via a non-circulating perfusion system at a constant flow rate. The perfusion medium was the Krebs-Henseleit solution (pH = 7.4, 37°C) composed of (mmol); 117. An initial perfusion rate of 15 ml/min for 5 min was followed by a 15 min equilibration period at a perfusion rate of 10 ml/min. All experimental measurements were done after this equilibration period.
Perfusion pressure
Evaluation of measurements of perfusion pressure changes induced by drugs administration in this study were assessed using a pressure transducer connected to the chamber where the hearts were mounted and the results entered into a computerized data capture system (Biopac).
Inotropic activity
Contractile function was assessed by measuring left ventricular developed pressure (LV/dP), using a saline-filled latex balloon (0.01 mm, diameter) inserted into the left ventricle via the left atrium 16 . The latex balloon was bound to cannula which was linked to pressure transducer that was connected with the MP100 data acquisition system.
First stage Ischemia/Reperfusion model
After of 15-minute equilibration time, the hearts were subjected to ischemia for 30 minutes by turning off the perfusion system 17 . After this period, the system was restarted and the hearts were reperfused by 30 minutes with Krebs-Henseleit solution. The hearts were randomly divided into 2 major treatment groups with n = 9: Group I. Hearts were subjected to ischemia/ reperfusion but received vehicle only (KrebsHenseleit solution)
Group II. Hearts were subjected to ischemia/ reperfusion and treated with the naphthalene derivative (0.001 nM) before ischemia period (for 10 minutes) and during the entire period of reperfusion. At the end of each experiment, the perfusion pump was stopped, and 0.5 ml of fluorescein solution (0.10%) was injected slowly through a sidearm port connected to the aortic cannula. The dye was passed through the heart for 10 sec to ensure its uniform tissue distribution. The presence of fluorescein was used to demarcate the tissue that was not subjected to regional ischemia, as opposed to the risk region. The heart was removed from the perfusion apparatus and cut into two transverse sections at right angles to the vertical axis. The right ventricle, apex, and atrial tissue were discarded. The areas of the normal left ventricle non risk region, area at risk, and infarct region were determined using methods previously reported 18 . Total area at risk was expressed as the percentage of the left ventricle.
Second stage Effect induced by the compounds 4-nitrobenzoyl azide, 2-hydroxy-1-naphthaldehyde and the naphthalene derivative on perfusion pressure
Changes in perfusion pressure as a consequence of increases in time (3 to 18 min) in absence (control) or presence of the compounds 4-nitrobenzoyl azide, 2-hydroxy-1-naphthaldehyde and the naphthalene derivativeat a concentration of 0.001 nM were determined. The effects were obtained in isolated hearts perfused at a constant-flow rate of 10 ml/min.
Evaluation of effects exerted by the compounds 4-nitrobenzoyl azide, 2-hydroxy-1-naphthaldehyde and the naphthalene derivativeon coronary resistance
The coronary resistance in absence (control) or presence of the compounds 4-nitrobenzoyl azide, 2-hydroxy-1-naphthaldehyde and the naphthalene derivative at a concentration of 0.001 nM was evaluated. The effects were obtained in isolated hearts perfused at a constant flow rate of 10 ml/min. Since a constant flow was used changes in coronary pressure reflected the changes in coronary resistance.
Third stage
Effects induced by the naphthalene derivative on left ventricular pressure through ± 1 -adrenergic receptor Intracoronary boluses (50 ¼l) of the naphthalene derivative(0.001 to 100 nM) were administered and the corresponding effect on the left ventricular pressure was determined. The dose-response curve (control) was repeated in the presence of prazosin at a concentration of 1 nM (duration of preincubation with prazosin was by a 10 min equilibration period).
Effects induced by the naphthalene derivative on left ventricular pressure through ² 1 -adrenergic receptor
Intracoronary boluses (50 ¼l) of the naphthalene derivative(0.001 to 100 nM) were administered and the corresponding effect on the left ventricular pressure was determined. The doseresponse curve (control) was repeated in the presence of propranolol or metoprolol at a concentration of 1 nM (duration of preincubation with propanolol or metoprolol was by a 10 min equilibration period).
Effect exerted by the naphthalene derivativeon left ventricular pressure in the presence of indomethacin
The boluses (50 ¼l) of the naphthalene derivative[0.001 to 100 nM] were administered and the corresponding effect on the left ventricular pressure was evaluated. The bolus injection administered was done in the point of cannulation. The dose response curve (control) was repeated in the presence of indomethacin at a concentration of 1 nM (duration of the pre-incubation with indomethacin was for a period of 10 min). 
Effects induced by the naphthalene derivative on the intracellular calcium levels
Changes in calcium levels as a consequence of increases in time (3-18 min) induce by the naphthalene derivative at a dose of 0.001nM (dose minimum) were evaluated. The dose-response curve (control) wasrepeated in the presence of nifedipine at a concentration of 1 nM mmol (duration ofpreincubation with nifedipine was by a 10 minequilibration period).It is important to mention, that intracellular calcium was evaluatedusing previously methods reported [18] . In thismethod, 5 mL of samples obtained of perfused (metabolic solution)were used to evaluate the intracellular calcium. It is important tomention that the samples were taken every 3 min (six times). After,4 ml trifluoroacetic acid (10%) was added each to sample. Thissolution was mixed for 5 min at room temperature and after 1 ml ofNaOH (25%) was added. To mixture 1 ml was trisodic phosphateadded and the mixture was vortexed (1 min) and centrifuged to4000 rpm (5 min). The supernatant was separated from theaqueous solution. After 5 mL of a buffer solution (pH = 10) and 3 mlof eriochromeblack was added to the aqueous solution. The mixturewas titled with ethylenediaminetetraaceticacid (EDTA) (f = 0.847).
Statistical analysis
The obtained values are expressed as average ± SE, using each heart (n = 9) as its own control. The data obtained were put under Analysis of Variance (ANOVA) with the Bonferroni correction factor using the SPSS 12.0 program 19 . The differences were considered significant when p was equal or smaller than 0.05.
RESULTS
Chemical synthesis
The yieldof the reaction product (compound 3, Figure 1 ) was 45 %with melting point of 188-190 
Biological activity First stage
In order to evaluate the activity of the naphthalene derivative on injury by ischaemia/ reperfusion an isolated heart model was used. The results showed that the naphthalene derivative reduced infarct size (expressed as a percentage of the area at risk) compared with vehicle-treated hearts (Figure2 and 3) .
Second stage
The activity induced by estradiol and its derivatives on perfusion pressure and coronary resistance in the isolated rat hearts was evaluated. The results (Figure 4) showed that the naphthalene derivative (0.001 nM) significantly increase the perfusion pressure (p = 0.05) over time (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) 
THIRD STAGE
Other results showed that activity exerted by the naphthalene derivative increases the left ventricular pressure at dose of 0.001 to 100 nM and this effect was not inhibited by prazosin, propanolol, metoprolol ( Figure 6 ) or indomethacin( Figure 7) at dose of 1 nM. 
Fourth stage
Other results (Table 3) showed that the naphthalene derivative increase the levels of intracellular calcium as a consequence of increases in the time; nevertheless, this effect is significantly reduced by nifedipine (1 nM).
DISCUSSION
Synthesis chemical
There are several procedures for the synthesis of naphtalen-derivatives [20] [21] [22] ; nevertheless, expensive reagents and special conditions are required; therefore, in this study a new naphthalenederivative was synthesized by the reaction of pnitrobenzoyl azide with 2-hydroxy-1-naphthaldehyde in acid medium (Figure 1 ). The structure of the 18 and 142.02-152.64 ppm for phenyl group; at 175.08 ppm for amide group; at 179.00 for carbon bound to both hydroxyl and amide groups. Finally, the presence of the naphthalene derivativewas further confirmed from mass spectrum which showed a molecular ion at m/z 336.06.
Biological activity
There are several reports which indicate that some drugs have been used to treat the infarction/ reperfusion injury resulting from myocardial ischemia [23] [24] [25] ; nevertheless, there is scarce information about the effects induced by some naphthalene derivatives involved this phenomenon. Therefore, in this study the activity of a naphthalene derivative on the infarction/reperfusion injury was evaluated using several strategies.
First stage
In order to evaluate the activity of the naphthalene derivative on injury by ischaemia/ reperfusion an isolated heart model was used. The results showed that the naphthalene derivative reduced infarct size. This phenomenon induced by the naphthalene derivative can be byactivation of some structure biological (p.e. ionic channels or specific receptors) involved in the endothelium of coronary artery 26 or by the influence exerted by the naphthalene derivative on blood pressure which could result reduction in the infarct size, and decrease the myocardial injury after ischemia-reperfusion; it is important to mention that this effect was similar to other reports for other type of drugs 27 .
In order to evaluate this hypothesis, the activity induced by the naphthalene derivative on blood vessel capacity and coronary resistance; translated as changes in perfusion pressure was evaluated in an isolated rat heart model. The results showed that the naphthalene derivative significantly increase the perfusion pressure over time. Analyzing this data and evaluating the possibility that functional groups involved in the chemical structure of naphthalene derivative could be by itself the responsible of their activity on perfusion pressure or coronary resistance; in this study, the compounds 4-nitrobenzoyl azide and 2-hydroxy-1-naphthaldehyde were used such pharmacological tool. The results showed that perfusion pressure was not affected in presence of 4-nitrobenzoyl azide and 2-hydroxy-1- ± 0.76 naphthaldehyde; therefore,these data confirm that functional groups different involved in the naphthalene derivative are the responsible of the activity exerted on perfusion pressure, which could result in changes in coronary resistance. To evaluate this hypothesis, the effects induced by the naphthalene derivative, 4-nitrobenzoyl azide and 2-hydroxy-1-naphthaldehyde on coronary resistance were evaluated. The results showed that coronary resistance was higher in presence of the naphthalene derivative in comparison with these compounds.
On the other hand, in the search of molecular mechanism of activity induced by the naphthalene derivative on perfusion pressure, in this study was analyzed a report, which indicates that somenaphthalene-derivatives can induce changes on blood pressure via adrenergic system 7 . To evaluate these hypotheses, the activity exerted by the naphthalene-derivativeon left ventricular pressure in the absence or presence of prazosin, propanolol or metoprolol was evaluated. The results showed that naphthalene derivative increases the left ventricular pressure in a manner dose-dependent and this effect was not inhibited by prazosin, propanolol or metoprolol. All these data indicate that the molecular mechanism involved in the effects of this compound on left ventricular pressure was not through adrenergic activity. In addition, also were analyzing other reportswhich indicate that some drugs may induce its effect on left ventricular pressure via prostaglandins synthesis 29 ; therefore, in this study the activity exerted by the naphthalene derivativeon left ventricular pressure in the absence or presence of indomethacin was examined to evaluate the possibility that the activities exerted by the naphthalene derivativeinvolve stimulation and secretion of prostaglandins. The results showed that the naphthalene derivativeincreased the left ventricular pressure and this effect was not blocked in presence of indomethacin; these data indicate that activity exerted by the naphthalene derivativeon left ventricular pressure was not via prostanoids synthesis.
Analyzing these data and other studies which suggest that some steroid derivatives can exert their activity on left ventricular pressure throughcalcium channels activation [29] ; in this study, the effect exerted by the naphthalene derivativeon left ventricular pressure was evaluated using nifedipine as pharmacological tool to characterize whether this mechanism was involved in their pharmacological activity. The results showed that the naphthalene derivativeincreases the left ventricular pressure in a dose dependent manner;however, this effect was blocked in presence of nifedipine. These data suggest that activity exerted by the naphthalene derivativewas via calcium channel type L activation. Nevertheless, to evaluate this hypotheses and analyzing other reports which suggested that the effect exerted by some drugs on left ventricular pressure involving increase in intracellular calcium 30 . In this study the effect induced by the naphthalene derivative on intracellular calcium concentration trough of time was evaluated in absence or presence of nifedipine. The results showed that the naphthalene derivative increase the levels of intracellular calcium as a consequence of increases in the time; nevertheless, this effect is significantly reduced by nifedipine.Therefore, all these data indicate that activity exerted by the naphthalene derivative was via calcium channels type Lwhich brings consequentlyan increasing in the calcium intracellular concentration.
CONCLUSIONS
The naphthalene derivativeis a particularly interesting drug, because the activity induced for this compound on injury by ischemia/reperfusioninvolves a molecular mechanism different in comparison with other drugs. This phenomenon may constitute a novel therapy for ischemia/reperfusion injury.
